ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Agilent to Showcase New Dako Omnis Family at European Congress of Pathology 2025

Agilent Technologies Inc. (NYSE: A) today announced its participation as a premium sponsor at the upcoming European Congress of Pathology (ECP) 2025, taking place in Vienna, Austria, from September 6–10, 2025. Agilent will spotlight the European launch of its newly expanded Dako Omnis Family of instruments.

The Dako Omnis family, including the Dako Omnis 110, 165, and 165 Duo models, is built to provide flexibility, consistency, and efficiency across labs of all sizes. Designed to meet the evolving needs of modern pathology labs, these instruments, are backed up by Agilent’s dedicated service and support teams to help ensure reliable operations and confident diagnoses.

“Our presence at ECP 2025 underscores Agilent’s dedication to supporting diagnostic excellence,” said Majken Nielsen, associate vice president of Marketing and Product Management, Clinical Diagnostics Division at Agilent. “The launch of the Dako Omnis family is a direct response to the challenges that labs face today. It marks a significant milestone in Agilent’s commitment to delivering scalable, high-performance diagnostic solutions that empower labs to meet increasing demands with confidence.”

As a premium sponsor, visitors to the Agilent booth will have the opportunity to:

  • See a live demo of the Dako Omnis family
  • Engage with Agilent experts during “Meet the Experts” sessions
  • Attend educational symposia:
    • Sunday, 7th September: Evening Symposium “Importance of the Quality of Stain, Optimized Workflow, and a Modern Digital Ecosystem
    • Tuesday, 9th September: Lunch Symposium “From Biopsy to Bedside: Integrating Diagnosis, Treatment, and Quality in Gastric Cancer
  • Explore Agilent’s end-to-end Digital Pathology solutions
  • Participate in PD-L1 CPS scoring sessions at the Educational Corner

To see these innovations and more, visit Agilent at ECP 2025 in Vienna, at booth #18.

About Agilent Technologies

Agilent Technologies Inc. (NYSE: A) is a global leader in analytical and clinical laboratory technologies, delivering insights and innovation that help our customers bring great science to life. Agilent’s full range of solutions includes instruments, software, services, and expertise that provide trusted answers to our customers' most challenging questions. The company generated revenue of $6.51 billion in fiscal year 2024 and employs approximately 18,000 people worldwide. Information about Agilent is available at www.agilent.com. To receive the latest Agilent news, subscribe to the Agilent Newsroom. Follow Agilent on LinkedIn and Facebook.

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.